Pain control after orthopedic surgery is challenging. A multimodal approach provides superior analgesia with fewer side effects compared with opioids alone. This approach is particularly useful in light of the current opioid epidemic in the United States. Several new nonopioid agents have emerged into the market in recent years. New agents included in this review are intravenous acetaminophen, intranasal ketorolac, and newer nonsteroidal anti-inflammatory drugs, and the established medications ketamine and gabapentinoids. This article evaluates the evidence supporting these drugs in a multimodal context, including a brief discussion of cost.
Keywords: Acetaminophen; Celecoxib; Gabapentinoids; Ibuprofen; Ketamine; Ketorolac; Multimodal analgesia; Orthopedic surgery.
Copyright © 2018 Elsevier Inc. All rights reserved.